Pembrolizumab + Lenvatinib
Treatment used for 1 condition
Total Trials
26
Total Participants
0K
Avg Effectiveness
90%
Avg Safety Score
30%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 1 condition
Click on a condition to view detailed treatment information and clinical trial data.